Abbott (NYSE:ABT) announced today that it received CE mark approval for its dual glucose-ketone sensing technology for people ...

The Libre Duo systems are the first glucose-ketone monitors to reach the diabetes market.

Healthcare major Abbott has launched its next-generation continuous glucose monitoring (CGM) device, the FreeStyle Libre 2 Plus, in India, offering real-time glucose readings every minute and optional ...

The world's first dual continuous glucose and ketone monitor is designed to help prevent diabetic ketoacidosis (DKA).

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The FDA designated this a Class I Recall after 860 serious injuries and 7 deaths were reported related to falsely low glucose readings. Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and ...

Abbott Diabetes Care's Freestyle Libre Flash Glucose Monitoring System has been approved by the FDA. As well as finally bringing the system, which is already available in 39 other countries, home to ...

CGMs can help people avoid serious diabetes complications, save money through better management and adjust behavior based on ...

The fastest way to make a CGM last the full wear period is to prep the application site carefully.

DexCom is the unrivaled king of the CGM market especially as it relates to various artificial pancreas development efforts. A new deal between Abbott and startup Bigfoot Medical may be the beginnings ...